Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Stochastic production of abnormal proteins
- Protein quality control mechanisms (PQC)
- PQC locations (1)
- Protein aggregation diseases of the nucleus
- Nuclear PQC mechanisms in yeast
- Is SAN1 a nuclear PQC gene
- Key features of a PQC degradation system (1)
- Loss of SAN1 stabilizes mutant proteins
- Mutant proteins specifically targeted by san1
- San1 Is nuclear localized
- How San1 functions
- The San1 degradation pathway
- San1's topology
- San1 interacts with substrates via 2-hybrid
- San1 ubiquitinates substrates in vitro
- San1 is predicted to be disordered
- San1 is intrinsically disordered by CD
- What high disorder means
- How San1 uses its flexible regions
- Prediction of San1 binding sites
- 2 models
- San1 distinctly interacts with each substrate
- Models of substrate binding
- San1 recognition of misfolded substrates
- Key features of a PQC degradation system (2)
- San1 and hydrophobicity
- Hydrophobicity is necessary and sufficient
- San1-interacting & non-interacting peptides
- Hydrophobicity as a San1 substrate determinant
- Substrates with complex hydrophobicity profiles
- Substrates with simple hydrophobicity profiles
- Rad16* hydrophobic region
- Ura3 temperature-sensitive point mutants
- Exposed hydrophobicity in Ura3 (1)
- Exposed hydrophobicity in Ura3 (2)
- Consequences of exposed hydrophobicity
- Many San1 substrates are toxic
- Rad16* hydrophobicity important in San1 toxicity
- Rad16* aggregates in the cell
- Non aggregating Rad16* mutant
- Important features of the San1 PQC
- Other nuclear PQC degradation pathways
- Potential nuclear PQCs - Yeast, Mammals
- The nucleus as a final destination
- PQC locations (2)
- Cytoplasmic misfolded proteins (1)
- Cytoplasmic misfolded proteins (2)
- Cytoplasmic chaperones and nuclear trafficking
- Open questions for nuclear PQC degradation
- Acknowledgements
- References
Topics Covered
- Ubiquitin-mediated degradation of misfolded proteins in the nucleus
- Protein aggregation in the nucleus
- Toxicity of protein aggregates
Talk Citation
Gardner, R.G. (2012, February 2). Nuclear protein quality control degradation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/DQXI2911.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Richard G. Gardner has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.